- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 16.04. | Polarean Imaging PLC - U.S. Patent granted for Xenon MRI | 2 | RNS | ||
| 14.03. | Polarean Imaging PLC - Exercise of Warrants, Issue of Equity and TVR | - | RNS | ||
| 12.03. | Polarean Imaging PLC - Holding(s) in Company | - | RNS | ||
| 29.02. | Polarean Imaging shares sink after announcing a costly strategic plan | 1 | Alliance News | ||
| 29.02. | Polarean Imaging PLC - 2024 Polarean Strategy Update | - | RNS | ||
| 15.01. | IN BRIEF: Polarean Imaging strategic parter raises stake to above 10% | 1 | Alliance News | ||
| 15.01. | Polarean Imaging PLC - Comment re: share purchase | - | RNS | ||
| 12.01. | Polarean Imaging PLC - Holding(s) in Company | - | RNS | ||
| 07.12.23 | SmallCap Round Up: Smart Metering Systems, Polarean Imaging, Premier African Minerals | 6 | The Armchair Trader | ||
| 07.12.23 | Polarean gets first de novo order for Xenoview polariser | 1 | Sharecast | ||
| 07.12.23 | IN BRIEF: Polarean shares jump on Xenoview polariser order | 1 | Alliance News | ||
| 07.12.23 | AIM WINNERS & LOSERS: Smart Metering accepts offer; order for Polarean | 1 | Alliance News | ||
| 07.12.23 | Polarean Imaging PLC - Company Update | - | RNS | ||
| 27.11.23 | Polarean Imaging PLC - Holding(s) in Company | 1 | RNS | ||
| 21.06.23 | Polarean Imaging plc: Appointment of Dr. Christopher von Jako as new CEO | 616 | GlobeNewswire (Europe) | Durham, N.C., June 21, 2023 (GLOBE NEWSWIRE) -- Polarean Imaging plc (AIM: POLX), the medical imaging company, announces that the Company's Board of Directors has appointed Christopher von Jako, Ph.D.... ► Artikel lesen |
15 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| MEDTRONIC | 73,99 | -1,49 % | Medtronic: Americans Favor Quality Over Quantity in Pursuit of Longevity | According to a new survey from Medtronic and Morning Consult, nearly two-thirds of U.S. adults say they'd opt for a shorter, healthier life than a longer one with health issuesDUBLIN, IRELAND / ACCESSWIRE... ► Artikel lesen | |
| HCA HEALTHCARE | 295,50 | -0,94 % | Catheter Precision, Inc. Announces Receipt of First Purchase Order for LockeT from HCA Healthcare Facility | FORT MILL, SC / ACCESSWIRE / April 24, 2024 / Catheter Precision, Inc. (NYSE American:VTAK) ($VTAK), a leading MedTech company specializing in innovative products for cardiac electrophysiology, including... ► Artikel lesen | |
| AMEDISYS | 83,50 | 0,00 % | Amedisys, Inc.: Amedisys Reports First Quarter 2024 Financial Results | BATON ROUGE, La., April 24, 2024 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three-month period ended March 31, 2024. Three-Month Periods Ended March... ► Artikel lesen | |
| LANTHEUS | 60,10 | -1,35 % | Lantheus Holdings, Inc.: Lantheus to Host First Quarter 2024 Earnings Conference Call and Webcast on May 2, 2024, at 8:00 a.m. Eastern Time | ||
| ENVISTA | 18,400 | 0,00 % | Envista Holdings Corporation: Envista Announces CEO Appointment | BREA, Calif., April 15, 2024 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) announced today the appointment of Paul Keel as Chief Executive Officer and a member of the Board of Directors... ► Artikel lesen | |
| CAREDX | 7,346 | -3,72 % | CareDx, Inc.: CareDx und Mitarbeiter präsentieren neueste Herz-Thorax-Fortschritte im Rahmen des 2024 International Society for Heart and Lung Transplantation Meeting | Neuester Abstract-Vortrag zur Präsentation der Ergebnisse des SHORE-Registers, das die Vorteile einer Überwachung mit HeartCare hervorhebt
CareDx, Inc. (Nasdaq: CDNA)- The Transplant Company ein... ► Artikel lesen | |
| GT BIOPHARMA | 3,670 | +2,51 % | GT Biopharma, Inc.: GT Biopharma Reports Fourth Quarter and Full-Year 2023 Financial Results | Remain in active dialogue with the FDA regarding IND clearance for GTB-3650, a 2nd generation nanobody TriKE® for treatment of CD33+ leukemiaPhase 1 trial with GTB-3650 anticipated to start in 2H... ► Artikel lesen | |
| SYNEOS HEALTH | 40,000 | 0,00 % | Research and Markets: 2024 Biopharmaceutical Sponsor Interaction with Clinical Site Networks Pulse Report Featuring IQVIA, ICON, Parexel, Fortrea (formerly Labcorp), PPD/Thermo Fisher, and Syneos Health - ResearchAndMarkets.com | The "2024 Biopharmaceutical Sponsor Interaction with Clinical Site Networks Pulse Report" has been added to ResearchAndMarkets.com's offering.
The biopharmaceutical clinical development landscape... ► Artikel lesen | |
| CARMAT | 3,150 | -13,93 % | CARMAT Announces Its 2023 Annual Results and Provides an Update on Its Progress and Prospects for 2024 | 2023 sales of €2.8 million, i.e. 17 Aeson® implants, including 11 in the last quarter
2024 sales forecast of around €14 million
Active exploration of financing options to extend... ► Artikel lesen | |
| CHEMOMETEC | 38,300 | +0,26 % | Chemometec A/S: Clarification of guidance for revenue and lower than expected operating profit in the 2023/24 financial year | ANNOUNCEMENT NO. 261 Clarification of guidance for revenue and lower than expected operating profit in the 2023/24 financial year According to the preliminary figures, revenue in the third quarter... ► Artikel lesen | |
| HAMILTON THORNE | 0,910 | 0,00 % | Bloom Burton & Co. Inc.: Hamilton Thorne Ltd. to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference | Beverly, Massachusetts--(Newsfile Corp. - April 10, 2024) - Hamilton Thorne Ltd. (TSX: HTL) (OTC Pink: HTLZF), Hamilton Thorne Ltd. a leading provider of precision instruments, laboratory equipment... ► Artikel lesen | |
| ARRAIL GROUP | 0,650 | +2,36 % | ARRAIL GROUP (06639): NEXT DAY DISCLOSURE RETURNS | ||
| DEVYSER DIAGNOSTICS | 8,280 | -0,48 % | Devyser Diagnostics AB: Devyser Diagnostics publishes year-end report for January to December 2023 | "Devyser is able to report strong sales growth and record high gross margins for the fourth quarter. During the quarter, Devyser continued to demonstrate the competitiveness of its products by winning... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 52,30 | -0,87 % | DAX & Co: Sartorius, Netflix, Siemens Healthineers, LVMH, Aixtron und Rheinmetall im Fokus | Der DAX hat am Mittwoch seine Gewinne bis zum Handelsende wieder vollständig abgegeben. Am Ende ging er mit einem Plus von 0,02 Prozent auf 17.770,02 Zähler über die Ziellinie. Am heutigen Donnerstag... ► Artikel lesen | |
| FRESENIUS | 27,180 | -0,51 % | Cardiol Therapeutics, Bayer AG, Fresenius Aktie - wer ist der Trendsetter im Gesundheitsmarkt von morgen? | Die Gesundheitsbranche ist ein lukratives Segment für risikobewusste Anleger. Die globale Marktgröße für Gesundheitsdienstleistungen wird voraussichtlich bis 2028 eine jährliche Wachstumsrate (CAGR)... ► Artikel lesen |
POLAREAN IMAGING PLC gehört der Branche Gesundheitswesen an. Die relative Kursveränderung beträgt aktuell 0,00 % bei einem Aktienkurs von 0,015 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
